Cargando…
Association of Cardiovascular Outcomes and Mortality With Sustained Long-Acting Insulin Only vs Long-Acting Plus Short-Acting Insulin Treatment
IMPORTANCE: Cardiovascular events and mortality are the principal causes of excess mortality and health care costs for people with type 2 diabetes. No large studies have specifically compared long-acting insulin alone with long-acting plus short-acting insulin with regard to cardiovascular outcomes....
Autores principales: | Schroeder, Emily B., Neugebauer, Romain, Reynolds, Kristi, Schmittdiel, Julie A., Loes, Linda, Dyer, Wendy, Pimentel, Noel, Desai, Jay R., Vazquez-Benitez, Gabriela, Ho, P. Michael, Anderson, Jeffrey P., O’Connor, Patrick J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463942/ https://www.ncbi.nlm.nih.gov/pubmed/34559229 http://dx.doi.org/10.1001/jamanetworkopen.2021.26605 |
Ejemplares similares
-
Comparison of Mortality and Major Cardiovascular Events Among Adults With Type 2 Diabetes Using Human vs Analogue Insulins
por: Neugebauer, Romain, et al.
Publicado: (2020) -
Effects of Ultra-Long-Acting Insulin Compared to Long-Acting Insulin on Diabetic Ketoacidosis Incidence in Type 1 Diabetes Mellitus Patients
por: Alsofiani, Wafa A, et al.
Publicado: (2022) -
Long-acting insulin allergy in a diabetic child
por: Mastrorilli, Carla, et al.
Publicado: (2017) -
Persistent Hypoglycemia Induced by Long-acting Insulin Degludec
por: Katakura, Yukino, et al.
Publicado: (2021) -
Diabetic Ketoacidosis Updates: Titratable Insulin Infusions and Long-Acting Insulin Early
por: Kinney, Justin, et al.
Publicado: (2021)